Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Screening of ordinary commercial varieties of apple fruits under different storage conditions for their potential vascular and metabolic protective properties.

Soleti R, Hilairet G, Mallegol P, Dourguia C, Frifra M, Guillou MC, Gacel A, Guyot S, Pignon P, Basset L, Cadot Y, Renou JP, Orsel M, Andriantsitohaina R.

Food Funct. 2018 Nov 14;9(11):5855-5867. doi: 10.1039/c8fo00967h.

PMID:
30358797
2.

IL-26 Confers Proinflammatory Properties to Extracellular DNA.

Poli C, Augusto JF, Dauvé J, Adam C, Preisser L, Larochette V, Pignon P, Savina A, Blanchard S, Subra JF, Chevailler A, Procaccio V, Croué A, Créminon C, Morel A, Delneste Y, Fickenscher H, Jeannin P.

J Immunol. 2017 May 1;198(9):3650-3661. doi: 10.4049/jimmunol.1600594. Epub 2017 Mar 29.

3.

Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses.

Cunin P, Beauvillain C, Miot C, Augusto JF, Preisser L, Blanchard S, Pignon P, Scotet M, Garo E, Fremaux I, Chevailler A, Subra JF, Blanco P, Wilson MR, Jeannin P, Delneste Y.

Cell Death Dis. 2016 May 5;7:e2215. doi: 10.1038/cddis.2016.113.

4.

Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.

Simon A, Subra JF, Guilpain P, Jeannin P, Pignon P, Blanchard S, Garo E, Jaillon S, Chevailler A, Renier G, Puéchal X, Bottazzi B, Mantovani A, Delneste Y, Augusto JF.

PLoS One. 2016 Jan 21;11(1):e0147091. doi: 10.1371/journal.pone.0147091. eCollection 2016.

5.

Modulation of Cytokine Secretion Allows CD4 T Cells Secreting IL-10 and IL-17 to Simultaneously Participate in Maintaining Tolerance and Immunity.

Saito K, Pignon P, Ayyoub M, Valmori D.

PLoS One. 2015 Dec 28;10(12):e0145788. doi: 10.1371/journal.pone.0145788. eCollection 2015.

6.

Differential expression of the immunosuppressive enzyme IL4I1 in human induced Aiolos+, but not natural Helios+, FOXP3+ Treg cells.

Scarlata CM, Celse C, Pignon P, Ayyoub M, Valmori D.

Eur J Immunol. 2015 Feb;45(2):474-9. doi: 10.1002/eji.201444897. Epub 2015 Jan 16.

7.

CD4+ T effectors specific for the tumor antigen NY-ESO-1 are highly enriched at ovarian cancer sites and coexist with, but are distinct from, tumor-associated Treg.

Ayyoub M, Pignon P, Classe JM, Odunsi K, Valmori D.

Cancer Immunol Res. 2013 Nov;1(5):303-8. doi: 10.1158/2326-6066.CIR-13-0062-T. Epub 2013 Aug 19.

8.

Expression of MAGE-A3/6 in primary breast cancer is associated with hormone receptor negative status, high histologic grade, and poor survival.

Ayyoub M, Scarlata CM, Hamaï A, Pignon P, Valmori D.

J Immunother. 2014 Feb-Mar;37(2):73-6. doi: 10.1097/CJI.0000000000000013.

PMID:
24509169
9.

Human memory Helios- FOXP3+ regulatory T cells (Tregs) encompass induced Tregs that express Aiolos and respond to IL-1β by downregulating their suppressor functions.

Raffin C, Pignon P, Celse C, Debien E, Valmori D, Ayyoub M.

J Immunol. 2013 Nov 1;191(9):4619-27. doi: 10.4049/jimmunol.1301378. Epub 2013 Sep 25.

10.

CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.

Redjimi N, Raffin C, Raimbaud I, Pignon P, Matsuzaki J, Odunsi K, Valmori D, Ayyoub M.

Cancer Res. 2012 Sep 1;72(17):4351-60. doi: 10.1158/0008-5472.CAN-12-0579. Epub 2012 Jul 12.

11.

Human T(H)17 immune cells specific for the tumor antigen MAGE-A3 convert to IFN-γ-secreting cells as they differentiate into effector T cells in vivo.

Hamaï A, Pignon P, Raimbaud I, Duperrier-Amouriaux K, Senellart H, Hiret S, Douillard JY, Bennouna J, Ayyoub M, Valmori D.

Cancer Res. 2012 Mar 1;72(5):1059-63. doi: 10.1158/0008-5472.CAN-11-3432. Epub 2012 Jan 17.

12.

Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy.

Hamaï A, Duperrier-Amouriaux K, Pignon P, Raimbaud I, Memeo L, Colarossi C, Canzonieri V, Perin T, Classe JM, Campone M, Jézéquel P, Campion L, Ayyoub M, Valmori D.

PLoS One. 2011;6(6):e21129. doi: 10.1371/journal.pone.0021129. Epub 2011 Jun 17.

13.

Assessment of vaccine-induced CD4 T cell responses to the 119-143 immunodominant region of the tumor-specific antigen NY-ESO-1 using DRB1*0101 tetramers.

Ayyoub M, Pignon P, Dojcinovic D, Raimbaud I, Old LJ, Luescher I, Valmori D.

Clin Cancer Res. 2010 Sep 15;16(18):4607-15. doi: 10.1158/1078-0432.CCR-10-1485. Epub 2010 Jul 29.

14.

Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers.

Ayyoub M, Dojcinovic D, Pignon P, Raimbaud I, Schmidt J, Luescher I, Valmori D.

Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7437-42. doi: 10.1073/pnas.1001322107. Epub 2010 Apr 5.

15.

Improved vitrification method allowing direct transfer of goat embryos.

Guignot F, Bouttier A, Baril G, Salvetti P, Pignon P, Beckers JF, Touzé JL, Cognié J, Traldi AS, Cognié Y, Mermillod P.

Theriogenology. 2006 Sep 1;66(4):1004-11. Epub 2006 Apr 3.

PMID:
16581117
16.

RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: analysis of its mechanism of action.

Cuturi MC, Christoph F, Woo J, Iyer S, Brouard S, Heslan JM, Pignon P, Soulillou JP, Buelow R.

Mol Med. 1999 Dec;5(12):820-32.

17.

Prolongation of heart xenograft survival in a hamster-to-rat model after therapy with a rationally designed immunosuppressive peptide.

Brouard S, Cuturi MC, Pignon P, Buelow R, Loth P, Moreau A, Soulillou JP.

Transplantation. 1999 Jun 27;67(12):1614-8.

PMID:
10401770
18.

Hourly distribution of time of parturition in the domestic goat.

Bosc M, Guillimin P, Bourgy G, Pignon P.

Theriogenology. 1988 Jul;30(1):23-33.

PMID:
16726446

Supplemental Content

Loading ...
Support Center